V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
Biopharma & Life Sciences

Elanco Animal Health Executive Compensation (FY25)

ELAN · Executive and director compensation, fiscal 2023 to 2025
Data as of September 7, 2026Latest filing (8-K): May 27, 2026
297 figures on this page: 289 cited to the filing that reported them, 8 calculated from figures it prints. See the citations
Total compensation for Jeffrey Simmons, President and Chief Executive Officer, came to $14,925,756 in fiscal 2025, and Simmons' total was 0.6% higher than the $14,833,704 reported for fiscal 2024. Separately, the disclosed chief executive pay ratio for fiscal 2025 is 181:1, against median employee compensation of $82,675. The say-on-pay proposal drew 82.0% support at the meeting held May 21, 2026 for fiscal 2025, and companies named in the disclosed peer group include Agilent Technologies, Inc., Bausch Health Companies Inc., Biogen Inc., Catalent, Inc. and Charles River Laboratories International, Inc., among others.
Chief executive, fiscal 2025
◇
Jeffrey Simmons
Median of the other named officers
$3,911,229
5 officers, excluding the chief executive
Latest say-on-pay support
=
May 21, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Jeffrey Simmons: $14,833,704 → $14,925,756 (0.6% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Elanco Animal Health's chief executive and what were they paid?
Total compensation for Jeffrey Simmons, President and Chief Executive Officer, came to $14,925,756 in fiscal 2025. Simmons' total was 0.6% higher than the $14,833,704 reported for fiscal 2024.
What was Elanco Animal Health's say-on-pay result?
The say-on-pay proposal drew 82.0% support at the meeting held May 21, 2026 for fiscal 2025.
Which companies are in Elanco Animal Health's peer group?
Companies named in the disclosed peer group include Agilent Technologies, Inc., Bausch Health Companies Inc., Biogen Inc., Catalent, Inc. and Charles River Laboratories International, Inc., among others.
What is Elanco Animal Health's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 181:1, against median employee compensation of $82,675.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jeffrey Simmons
President and CEO
◇—◇◇◇—◇◇
Todd Young
Former Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Ellen de Brabander
Executive Vice President, Innovation and Regulatory
◇—◇◇◇—◇— not reconciled
Ramiro Cabral
Executive Vice President, President International
◇—◇◇◇—◇◇
Timothy Bettington
Executive Vice President, Center for Strategic Growth
◇◇◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jeffrey Simmons
President and CEO
◇—◇◇◇—◇◇
Todd Young
Former Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Ellen de Brabander
Executive Vice President, Innovation and Regulatory
◇—◇◇◇—◇◇
Ramiro Cabral
Executive Vice President, President International
◇—◇◇◇—◇◇
Timothy Bettington
Executive Vice President, Center for Strategic Growth
◇—◇◇◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jeffrey Simmons
President and Chief Executive Officer
◇—◇◇◇—◇◇
Todd Young
Former Executive Vice President and Chief Financial Officer
Departed during or after this year
◇—◇◇——◇◇
Robert VanHimbergen
Executive Vice President and Chief Financial Officer
◇◇◇◇◇—◇◇
Ellen de Brabander
Executive Vice President, Innovation and Regulatory Affairs
◇—◇◇◇—◇◇
Ramiro Cabral
Executive Vice President, President International
◇—◇◇◇—◇◇
Timothy Bettington
Executive Vice President, Center for Strategic Growth
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Jeffrey SimmonsPSU◇—◇—◇—◇
Jeffrey SimmonsRSU◇——◇——◇
Jeffrey SimmonsOPTION◇——◇—◇◇
Ramiro CabralOPTION◇——◇—◇◇
Ramiro CabralRSU◇——◇——◇
Ramiro CabralPSU◇—◇—◇—◇
Robert VanHimbergenRSU◇——◇——◇
Robert VanHimbergenRSU◇——◇——◇
Robert VanHimbergenOTHER◇——— withheld——◇
Timothy BettingtonOPTION◇——◇—◇◇
Timothy BettingtonRSU◇——◇——◇
Timothy BettingtonPSU◇—◇—◇—◇
Todd YoungRSU◇——◇——◇
Todd YoungRSU◇——◇——◇
Todd YoungOPTION◇——◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Dr. CabralOption◇—◇—
RSU◇◇——
Option◇—◇—
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇—
Mr. VanHimbergenRSU◇◇——
RSU◇◇——
Option◇—◇—
RSU◇◇——
RSU◇◇——
Option◇—◇—
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇—
Option◇—◇—
RSU◇◇——
Mr. BettingtonRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇—
Option◇—◇—
Mr. SimmonsRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇—
Option◇—◇—
Option◇—◇—
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Lawrence Kurzius
Board chair
◇◇————◇
Kirk McDonald
◇◇————◇
Michael Harrington
◇◇————◇
Deborah Kochevar
◇◇————◇
Paul Herendeen
◇◇————◇
Art Garcia
◇◇————◇
Denise Scots-Knight
◇◇————◇
R. David Hoover
◇◇————◇
Kapila Anand
◇◇————◇
Stacey Ma
◇◇————◇
John Bilbrey
◇◇————◇
Craig Wallace
◇◇————◇
Kathleen Turner
◇◇————◇
William Doyle
◇◇————◇
Jeffrey Simmons served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Compensation committee chair◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Agilent Technologies, Inc. A
  • Bausch Health Companies Inc. BHC
  • Biogen Inc. BIIB
  • Catalent, Inc. CTLT
  • Charles River Laboratories International, Inc. CRL
  • DENTSPLY SIRONA Inc. XRAY
  • Edwards Lifesciences Corporation EW
  • Hologic, Inc. HOLX
  • IDEXX Laboratories, Inc. IDXX
  • Incyte Corporation INCY
  • Jazz Pharmaceuticals plc JAZZ
  • Perrigo Company plc PRGO
  • QuidelOrtho Corporation QDEL
  • Revvity, Inc. RVTY
  • STERIS plc STE
  • Vertex Pharmaceuticals, Inc. VRTX
  • Zimmer Biomet Holdings, Inc. ZBH
  • Zoetis Inc. ZTS

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 21, 2026=◇◇◇
2024May 16, 2025=◇◇◇
2023May 30, 2024=◇◇◇
2022May 18, 2023=◇◇◇
2021May 18, 2022=◇◇◇
2020May 19, 2021=◇◇◇
2019May 21, 2020=◇◇◇
2018May 8, 2019=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Elanco Animal Health files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Elanco Animal Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Elanco Animal Health sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Elanco Animal Health's disclosed peer group is defensible, who names Elanco Animal Health back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
297 figures on this page: 289 cited to the filing that reported them, 8 calculated from figures it prints.
289 cited to the filing
8 calculated from the filing

Documents cited

  1. 0001104659-26-067002
  2. 0001739104-26-000016
    2025 NON-EMPLOYEE DIRECTOR COMPENSATION · CEO Pay Ratio · Grants of Plan-Based Awards · NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM · and 2 more sections
  3. 0001104659-25-051136
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001739104-25-000030
    Summary Compensation Table
  5. 0001104659-24-068253
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001140361-24-020680
    Summary Compensation Table
  7. 0001104659-23-062858
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0001104659-22-062946
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0001104659-21-070463
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0001104659-20-065392
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0001104659-19-028027
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Elanco Animal Health executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/ELAN (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Elanco Animal Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Biopharma & Life Sciences rankings

Chief executive pay — Biopharma & Life SciencesCEO pay ratio — Biopharma & Life SciencesSay-on-pay support — Biopharma & Life Sciences

Peers Elanco Animal Health discloses

The companies named in ELAN's own disclosed peer group.

Agilent Technologies, Inc.Biogen Inc.Charles River Laboratories International, Inc.DENTSPLY SIRONA Inc.Edwards Lifesciences CorporationHologic, Inc.Incyte CorporationJazz Pharmaceuticals plcRevvity, Inc.STERIS plcVertex Pharmaceuticals, Inc.Zimmer Biomet Holdings, Inc.Zoetis Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy